Jivan Biologics, Inc. Focuses on Solutions for Transcriptome Sequencing

LARKSPUR, Calif., April 9 /PRNewswire/ -- Jivan announced today that it will provide bioinformatics solutions for high-throughput transcriptome sequencing (RNA-Seq) and expression. Leveraging Jivan's industry-leading bioinformatics infrastructure for analysis of mRNA in biological samples, Jivan will provide "bioinformatics for the next generation." Jivan will offer content for targeted sequencing with mRNA capture arrays, mRNA specific PCR primer designs for targeted amplification, and software for analyzing mRNA expression from RNA-Seq, multiplexed PCR and microarrays.

"Jivan is uniquely situated to address the informatics challenges of transcriptome sequencing," said Subha Srinivasan, PhD, CEO of Jivan. "Our mRNA sequence databases, software infrastructure, oligonucleotide design capabilities, and expression analysis software give us a tremendous advantage in developing solutions for RNA sequencing."

Jivan has developed a database for analysis of mRNA expression from transcriptome sequencing. It enables advanced expression counts that go beyond the basic reads per kilo base (rpkb) that is the current standard.

To support RNA sequencing, Jivan's technology offering will include mRNA Capture Arrays for targeted sequencing of genomes, gene families and therapeutic areas. By using Jivan's database of mRNA sequences, including exons and exon junctions, Jivan can ensure the capture of all mRNA sequences of each gene of interest, including wildtype transcripts and splice variants. For genes or mRNAs with low expression, Jivan will offer mRNA Prime(TM) PCR primer designs specific to each observed mRNA.

To analyze RNA sequencing data, Jivan will offer a software tool called mRNA Magic(TM) that provides functionality for sophisticated expression analysis from sequence reads.

For more information, see http://www.jivanbio.com.

About Jivan

Jivan empowers scientists with new insight by providing a full range of products and services for mRNA sequencing and expression, including capture arrays, PCR primers and amplicons, and transcriptome sequencing software.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

CONTACT: Jonathan Bingham of Jivan Biologics, Inc., +1-415-425-4115,
jbingham@jivanbio.com

Web site: http://www.jivanbio.com/

MORE ON THIS TOPIC